Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08XGL
|
|||
Former ID |
DNC014448
|
|||
Drug Name |
(+/-)-threo-N-(3-Phenylpropyl)ritalinol
|
|||
Synonyms |
CHEMBL1254359; (+/-)-threo-N-(3-Phenylpropyl)ritalinol
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C22H29NO
|
|||
Canonical SMILES |
C1CCN(C(C1)C(CO)C2=CC=CC=C2)CCCC3=CC=CC=C3
|
|||
InChI |
1S/C22H29NO/c24-18-21(20-13-5-2-6-14-20)22-15-7-8-16-23(22)17-9-12-19-10-3-1-4-11-19/h1-6,10-11,13-14,21-22,24H,7-9,12,15-18H2/t21-,22-/m1/s1
|
|||
InChIKey |
QQICWLNJJOCDRX-FGZHOGPDSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
KEGG Pathway | Dopaminergic synapse | |||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Parkinson disease | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Dopaminergic Neurogenesis | ||||
Parkinsons Disease Pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | Quantitative structure-activity relationship studies of threo-methylphenidate analogs. Bioorg Med Chem. 2010 Oct 15;18(20):7221-38. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.